Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

CBST 63.95 +0.02 (0.03%)
price chart
What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.?
Cubist Pharmaceuticals (NASDAQ: CBST ) and Durata Therapeutics (NASDAQ: DRTX ) both won this week with nods by the FDA's advisory panels on each company's antibacterial agents. In two unanimous votes, the FDA panels agreed on the safety and ...
Related articles »  
Better Buy: Cubist Pharmaceuticals, Inc. vs. Durata Therapeutics, Inc.
Given the bipolar nature of regulatory decisions for biotechs, it's key to understand the risks relative to rewards associated with a company ahead of the event. With that in mind, here is a Foolish comparison of two biotechs, Cubist Pharmaceuticals ...
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICIN� (daptomycin for injection) to the user level due to the presence of particulate matter, reported via ...
Cubist Pharmaceuticals Inc.: Cubist to Announce First Quarter 2014 Financial ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first quarter 2014 financial results at 4:00 p.m.
Related articles »  
Cubist Pharma Recalls One Lot Of Cubicin Due To Presence Of Particulate Matter
Cubist Pharmaceuticals, Inc. (CBST: Quote) said Friday that it is voluntarily recalling one lot of Cubicin to the user level due to the presence of particulate matter, reported through customer complaint and identified as glass particles, found in a ...
Related articles »  
Cubist Pharmaceuticals Given �Buy� Rating at Aegis (CBST)
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST)'s stock had its �buy� rating reiterated by analysts at Aegis in a research report issued to clients and investors on Tuesday, Analyst Ratings Network reports.
Cubist Appoints Robert J. Perez to Board of Directors
From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals. Mr. Perez is a Director at AMAG Pharmaceuticals, Inc. and from 2006 - 2009 served as a Director at EPIX Pharmaceuticals, Inc. He is also a Trustee of the ...
Related articles »  
Cubist Pharmaceuticals Issues Voluntary Recall of Tainted Cubicin Lot
Cubist Pharmaceuticals Inc. (CBST) said Friday that it is voluntarily recalling a lot of Cubicin treatment after a customer reported finding glass particles in a vial.
Why MannKind (MNKD) is Outpacing these Biotech Stocks, Questcor ...
Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) shares moved up 2% after the company reported that it would issue its first quarter 2014 financial results at 4:00 p.m.
Related articles »  
News Recap - TherapeuticsMD Inc (NYSEMKT:TXMD), Alnylam ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) reported 1.50 million shares were exchanged during the last trade, while the average volume is about 794,229 shares.
Related articles »